User profiles for Karen Minde Fagerli
 | Karen Minde FagerliDiakonhjemmet Hospital Verified email at diakonsyk.no Cited by 1210 |
The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study
KM Fagerli, E Lie, D van der Heijde… - Annals of the …, 2014 - ard.bmj.com
Background The role of co-medication with tumour necrosis factor inhibitors (TNFi) is well
established in rheumatoid arthritis and ankylosing spondylitis. In psoriatic arthritis (PsA) there …
established in rheumatoid arthritis and ankylosing spondylitis. In psoriatic arthritis (PsA) there …
Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study
…, J Sexton, HB Hammer, KM Fagerli… - Annals of the …, 2017 - ard.bmj.com
Objective To investigate the predictive value of baseline depression/anxiety on the likelihood
of achieving joint remission in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) as well …
of achieving joint remission in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) as well …
Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study
KM Fagerli, E Lie, D van der Heijde… - Annals of the …, 2013 - ard.bmj.com
Background Tumour necrosis factor inhibitors (TNFi) are efficacious in patients with psoriatic
arthritis (PsA), but some patients do not respond or do not tolerate their first TNFi, and are …
arthritis (PsA), but some patients do not respond or do not tolerate their first TNFi, and are …
Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with …
…, EK Kristianslund, HB Hammer, KM Fagerli… - Annals of the …, 2017 - ard.bmj.com
Objective To investigate the predictive value of discordance between (1) tender and swollen
joint count and (2) patient's and evaluator's global assessment on remission in patients with …
joint count and (2) patient's and evaluator's global assessment on remission in patients with …
The yield of a positive MRI of the spine as imaging criterion in the ASAS classification criteria for axial spondyloarthritis: results from the SPACE and DESIR cohorts
…, R Van Den Berg, M Reijnierse, KM Fagerli… - Annals of the …, 2017 - ard.bmj.com
Objectives To assess the prevalence of spinal inflammation on MRI in patients with chronic
back pain (CBP) of maximally 3 years duration and to evaluate the yield of adding a positive …
back pain (CBP) of maximally 3 years duration and to evaluate the yield of adding a positive …
Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register
KM Fagerli, L Kearsley-Fleet, KD Watson… - RMD open, 2018 - rmdopen.bmj.com
Background Long-term effectiveness of tumour necrosis factor alpha inhibitors (TNFi) has
mainly been explored in patients with rheumatoid arthritis (RA) and the data available on …
mainly been explored in patients with rheumatoid arthritis (RA) and the data available on …
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis …
…, J Závada, N Atas, S Yolbas, KM Fagerli… - Annals of the …, 2021 - ard.bmj.com
Background Comedication with conventional synthetic disease-modifying antirheumatic drugs
(csDMARDs) during treatment with tumour necrosis factor inhibitors (TNFi) is extensively …
(csDMARDs) during treatment with tumour necrosis factor inhibitors (TNFi) is extensively …
Metric properties of the SPARCC score of the sacroiliac joints—data from baseline, 3-month, and 12-month followup in the SPACE cohort
…, V Navarro-Compán, KM Fagerli… - The Journal of …, 2015 - jrheum.org
Objective. To evaluate metric properties of the SpondyloArthritis Research Consortium of
Canada (SPARCC) score of the sacroiliac (SI) joints. Methods. Patients with back pain (≥ 3 …
Canada (SPARCC) score of the sacroiliac (SI) joints. Methods. Patients with back pain (≥ 3 …
Low specificity but high sensitivity of inflammatory back pain criteria in rheumatology settings in Europe: confirmation of findings from a German cohort study
…, MG van de Sande, R Ramonda, KM Fagerli… - Annals of the …, 2019 - ard.bmj.com
Inflammatory back pain (IBP) is considered so essential in the axial spondyloarthritis (axSpA)
diagnostic process that it is recommended as referral parameter in primary care. 1–3 …
diagnostic process that it is recommended as referral parameter in primary care. 1–3 …
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
…, F Iannone, A Ciurea, KM Fagerli… - The Journal of …, 2023 - jrheum.org
Objective To investigate the distribution of patient-reported outcomes (PROs) in patients with
axial spondyloarthritis (axSpA) initiating a tumor necrosis factor inhibitor (TNFi), to assess …
axial spondyloarthritis (axSpA) initiating a tumor necrosis factor inhibitor (TNFi), to assess …